Torben Straight Nissen, interim CEO of Repertoire Immune Medicines

Up­dat­ed: Flag­ship sends a vet — post-Ru­bius im­plo­sion — in­to the breach at Reper­toire

Flag­ship is send­ing in one of its se­nior part­ners to pick up the pieces at Reper­toire Im­mune Med­i­cines. And he has some ex­pe­ri­ence with set­backs.

This morn­ing the ven­ture in­vestor is­sued a state­ment — the first since we con­firmed the news Fri­day evening that the Reper­toire had laid off close to half its staff — that Flag­ship se­nior part­ner Tor­ben Straight Nis­sen, a Pfiz­er vet who took the pres­i­dent’s job at cell ther­a­py start­up Ru­bius, would take the in­ter­im helm at Reper­toire.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.